Client Challenge
A leading pharmaceutical manufacturing company sought to assess the treatment and reimbursement landscape, with specific focus on drug and emerging regimens. The key objectives for this project were to:
- Evaluate current treatment practices and payer perspectives
- Identify and access unmet needs shaping therapy adoption
- Gather expert feedback on Target Product Profiles (TPP) to guide future product and market-access strategy
GLG's Approach
GLG conducted 1:1 moderated interviews with oncologists and payers actively involved in this specific treatment and reimbursement, capturing clinical and payer perspectives and delivering results within two weeks.
Client Impact
A detailed report was shared, providing insights that informed:
- Treatment Dynamics Intelligence: Gained comprehensive insights into current treatment patterns and market perceptions shaping adoption of emerging therapies
- Unmet Needs Identification: Identified key clinical and access gaps, enabling refinement of product profiles and value messaging for future launches
- Strategic Decision Support: Strengthened planning with expert-validated evidence to inform pricing, reimbursement, and market-access decisions
